@girdhani_swati @yuanjamesrao @toddscarbrough 1)there is evidence of the opposite https://t.co/LAb61gx8kL 2)Don’t conflate public/healthcare policy with RCTs designed to improve oncologic outcomes. 3)Why do worse at all, in particular in resource rich nati
@seanmmcbride @MathieuSpaas @gv_lazcano @JAMAOnc @CVanpouilleBox Here is a phase 1 with an 87.5% DCR NCT03728179 HT @fg_herrera https://t.co/aAzOi6glda Again I hate use of term “negative” - for Freq its non informative, period
@piet_ost @NoraSundahl I’m paywalled for this article but did you look at low doses? https://t.co/LAb61gx8kL
The authors of "Low-Dose Radiotherapy Reverses Tumor Immune Desert…" (https://t.co/AC8kTq5Ep5) included RRIDs in their paper! Thank you for making your #methodsmatter. #RRID
@pipcosper @DKirschMDPhD @TheLancet @MoffittNews @AmyWisdom8 @YvonneMowery 8 Gy x 3 is BS. We need to be looking at various schemes of LOWER doses (0.5-2 Gy/fx) and looking hard at NKG2D, as well as SIRPa/CD47 @science_wallet @fg_herrera https://t.co/j1RxO
@jryckman3 @xrtGenomics @CJTsaiMDPhD @GeneCollector @imrtlee @rweichselbaum @HenningWillers @seanmmcbride @jdschoenfeld1 @DrHaddadRobert @sueyom I don’t think it’s that conventional fx is immunosuppressive 👇 https://t.co/LAb61gx8kL
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy | Cancer Discovery | American Association for Cancer Research #Low-doseRT #IO https://t.co/Zs5Hf7U2CJ
@TobiasFinazzi @SprakerMDPhD Is it? I’m scared we’re pigeonholed to less fractions. and missing perhaps low dose options which may have biological rationale https://t.co/LAb61gx8kL
RT @ElizSMcKenna: At the #AACR22 session on Radiation Sequencing & Immunotherapy? ICYMI in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor…
@leunger22 @Sunnybrook @LHSCCanada Preclinical and Phase 1 data to support LDRT as well 🤷♂️ https://t.co/j1RxOxipHx
Reprogramming the tumor microenvironment by Low dose #radiation #Immunotherapy Relevant study https://t.co/unCE4ECmQj
RT @ElizSMcKenna: At the #AACR22 session on Radiation Sequencing & Immunotherapy? ICYMI in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor…
RT @ElizSMcKenna: At the #AACR22 session on Radiation Sequencing & Immunotherapy? ICYMI in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor…
RT @ElizSMcKenna: At the #AACR22 session on Radiation Sequencing & Immunotherapy? ICYMI in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor…
RT @ElizSMcKenna: At the #AACR22 session on Radiation Sequencing & Immunotherapy? ICYMI in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor…
At the #AACR22 session on Radiation Sequencing & Immunotherapy? ICYMI in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification & #Immunotherapy Resistance @fg_herrera @melitairving @CoukosGeorge @OncoUNILCHUV @Ludwig_Cancer @CHUVLa
@JonathanVermaMD @lemmiwenks Instead of aromatase inhibitors? Why are we intellectually pigeonholing ourselves to less fractions, when maybe more fractions of lower dose RT has promise? 🤷♂️ https://t.co/LAb61gx8kL
RT @5_utr: @DavidLMayhew @sunjay_shah @SbrtSean Well said! This is actually an exciting time in our field as well with phase 1 https://t.co…
RT @5_utr: @DavidLMayhew @sunjay_shah @SbrtSean Well said! This is actually an exciting time in our field as well with phase 1 https://t.co…
@DavidLMayhew @sunjay_shah @SbrtSean Well said! This is actually an exciting time in our field as well with phase 1 https://t.co/R3xwBM0o4K, SIRPα as rational target (https://t.co/mKhykwM6Vn) and more!
RT @fg_herrera: From our recent published paper in @CD_AACR https://t.co/47zoPJaJzM As well as two important papers by Zachary Morris and…
From our recent published paper in @CD_AACR https://t.co/47zoPJaJzM As well as two important papers by Zachary Morris and James Welsh https://t.co/4nE9tqZFf1 https://t.co/LFc7jPldDU
RT @CD_AACR: From the January issue: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy by @fg_h…
RT @CD_AACR: From the January issue: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy by @fg_h…
RT @CD_AACR: From the January issue: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy by @fg_h…
RT @CD_AACR: From the January issue: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy by @fg_h…
RT @CD_AACR: From the January issue: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy by @fg_h…
From the January issue: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy by @fg_herrera, @melitairving, @CoukosGeorge, and colleagues @OncoUNILCHUV, @Ludwig_Cancer, @CHUVLausanne, @unil, @FondationIsrec. https:/
RT @ElizSMcKenna: Read it here: https://t.co/6085czduRv
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy | Cancer Discovery https://t.co/5kn785gTMF
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy [Research Articles] https://t.co/2IRxGWoboA
RT @ElizSMcKenna: Read it here: https://t.co/6085czduRv
Read it here: https://t.co/6085czduRv
RT @nachoduranm: Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy https://t.co/hMjyAWjLo0
RT @nachoduranm: Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy https://t.co/hMjyAWjLo0
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy https://t.co/hMjyAWjLo0
RT @nanostringtech: Are these the next steps towards firing up the tumor microenvironment? 🔥 Very proud to report GeoMx DSP was used to he…
Are these the next steps towards firing up the tumor microenvironment? 🔥 Very proud to report GeoMx DSP was used to help investigate the immune landscape of cancer in both untreated & #Immunotherapy treated patients. https://t.co/tQiWEY1pSi #Spatial
https://t.co/WL0tWxm9hf Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy -SBRT is great but perhaps immunologically we need SBRT-lite 🤔 #radonc
RT @OncoUNILCHUV: 𝘐𝘊𝘠𝘔𝘐 𝐍𝐄𝐖 𝐒𝐓𝐔𝐃𝐘 on how low-dose irradiation breaks down resistance to #Immunotherapy in cold tumors. Led @unil @CHUVLau…
RT @jitcancer: Oct @sitcancer #JITC Editor reading list Dr Demaria @WeillCornell #4 @CD_AACR Low Dose RT Reverses Tumor Immune Desertifica…
RT @jitcancer: Oct @sitcancer #JITC Editor reading list Dr Demaria @WeillCornell #4 @CD_AACR Low Dose RT Reverses Tumor Immune Desertifica…
RT @jitcancer: Oct @sitcancer #JITC Editor reading list Dr Demaria @WeillCornell #4 @CD_AACR Low Dose RT Reverses Tumor Immune Desertifica…
This is interesting work.
RT @jitcancer: Oct @sitcancer #JITC Editor reading list Dr Demaria @WeillCornell #4 @CD_AACR Low Dose RT Reverses Tumor Immune Desertifica…
RT @jitcancer: Oct @sitcancer #JITC Editor reading list Dr Demaria @WeillCornell #4 @CD_AACR Low Dose RT Reverses Tumor Immune Desertifica…
RT @jitcancer: Oct @sitcancer #JITC Editor reading list Dr Demaria @WeillCornell #4 @CD_AACR Low Dose RT Reverses Tumor Immune Desertifica…
RT @jitcancer: Oct @sitcancer #JITC Editor reading list Dr Demaria @WeillCornell #4 @CD_AACR Low Dose RT Reverses Tumor Immune Desertifica…
RT @jitcancer: Oct @sitcancer #JITC Editor reading list Dr Demaria @WeillCornell #4 @CD_AACR Low Dose RT Reverses Tumor Immune Desertifica…
Oct @sitcancer #JITC Editor reading list Dr Demaria @WeillCornell #4 @CD_AACR Low Dose RT Reverses Tumor Immune Desertification and Resistance to Immunotherapy @fg_herrera @CoukosGeorge @CHUVLausanne @OncoUNILCHUV @Ludwig_Cancer Low dose RT to rescue IO!
RT @ElizSMcKenna: Congratulations to #ESMO21 Translational Research Award winner @CoukosGeorge – check out his most recent work in @CD_AACR…
RT @ElizSMcKenna: Congratulations to #ESMO21 Translational Research Award winner @CoukosGeorge – check out his most recent work in @CD_AACR…
RT @ElizSMcKenna: Congratulations to #ESMO21 Translational Research Award winner @CoukosGeorge – check out his most recent work in @CD_AACR…
RT @ElizSMcKenna: Congratulations to #ESMO21 Translational Research Award winner @CoukosGeorge – check out his most recent work in @CD_AACR…
RT @ElizSMcKenna: Congratulations to #ESMO21 Translational Research Award winner @CoukosGeorge – check out his most recent work in @CD_AACR…
Congratulations to #ESMO21 Translational Research Award winner @CoukosGeorge – check out his most recent work in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy @fg_herrera @melitairving @OncoUNILCHUV
RT @NatRevClinOncol: Data from mouse models and a phase I clinical trial indicate that low-dose RT can reverses tumour immune desertificati…
RT @NatRevClinOncol: Data from mouse models and a phase I clinical trial indicate that low-dose RT can reverses tumour immune desertificati…
Data from mouse models and a phase I clinical trial indicate that low-dose RT can reverses tumour immune desertification and resistance to ICIs, predominantly by eliciting CD4+ Th1 cells expressing NKG2D as well as activated DCs expressing the NKG2D-L Rae1
RT @NatRevClinOncol: in a mouse model of ovarian cancer, low-dose chemoRT induced inflammation, immune-cell infiltration and myeloid reprog…
Nice work by @CoukosGeorge and his team on how low dose radiotherapy can be used for immunotherapy. Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy https://t.co/eUOznTiX5x
RT @NatRevClinOncol: in a mouse model of ovarian cancer, low-dose chemoRT induced inflammation, immune-cell infiltration and myeloid reprog…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy | Cancer Discovery https://t.co/DLmGlry1j9
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @OncoUNILCHUV: 𝘐𝘊𝘠𝘔𝘐 𝐍𝐄𝐖 𝐒𝐓𝐔𝐃𝐘 on how low-dose irradiation breaks down resistance to #Immunotherapy in cold tumors. Led @unil @CHUVLau…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @OncoUNILCHUV: 𝘐𝘊𝘠𝘔𝘐 𝐍𝐄𝐖 𝐒𝐓𝐔𝐃𝐘 on how low-dose irradiation breaks down resistance to #Immunotherapy in cold tumors. Led @unil @CHUVLau…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @OncoUNILCHUV: 𝘐𝘊𝘠𝘔𝘐 𝐍𝐄𝐖 𝐒𝐓𝐔𝐃𝐘 on how low-dose irradiation breaks down resistance to #Immunotherapy in cold tumors. Led @unil @CHUVLau…
RT @OncoUNILCHUV: 𝘐𝘊𝘠𝘔𝘐 𝐍𝐄𝐖 𝐒𝐓𝐔𝐃𝐘 on how low-dose irradiation breaks down resistance to #Immunotherapy in cold tumors. Led @unil @CHUVLau…
𝘐𝘊𝘠𝘔𝘐 𝐍𝐄𝐖 𝐒𝐓𝐔𝐃𝐘 on how low-dose irradiation breaks down resistance to #Immunotherapy in cold tumors. Led @unil @CHUVLausanne @Ludwig_Cancer by @CoukosGeorge @IrvingMelita. 1st author @fg_herrera. @CD_AACR 👉https://t.co/sHVy787Nxo /Supporting instituti
Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy | Cancer Discovery https://t.co/JYfE1Fr8KA
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @NatRevClinOncol: in a mouse model of ovarian cancer, low-dose chemoRT induced inflammation, immune-cell infiltration and myeloid reprog…
RT @NatRevClinOncol: in a mouse model of ovarian cancer, low-dose chemoRT induced inflammation, immune-cell infiltration and myeloid reprog…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
RT @CoukosGeorge: Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical transla…
Happy to share our story just out in #CancerDiscovery https://t.co/N7PxuO9Fuz. Very exciting science and clinical translation in a first-in-human clinical study at the #Ludwig Institute for Cancer Reserch and the #CHUV. Great work #fg_herrera and #IrvingMe
RT @ElizSMcKenna: Now online in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy @fg…
RT @NatRevClinOncol: in a mouse model of ovarian cancer, low-dose chemoRT induced inflammation, immune-cell infiltration and myeloid reprog…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
Term: low-dose radiotherapy.
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @NatRevClinOncol: in a mouse model of ovarian cancer, low-dose chemoRT induced inflammation, immune-cell infiltration and myeloid reprog…
vitally&urgently needed solutions by @CoukosGeorge @fg_herrera et al
RT @NatRevClinOncol: in a mouse model of ovarian cancer, low-dose chemoRT induced inflammation, immune-cell infiltration and myeloid reprog…
RT @NatRevClinOncol: in a mouse model of ovarian cancer, low-dose chemoRT induced inflammation, immune-cell infiltration and myeloid reprog…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
in a mouse model of ovarian cancer, low-dose chemoRT induced inflammation, immune-cell infiltration and myeloid reprogramming, potentiating activity of ICIs and forming basis for a phase I trial of low-dose chemoRT + ICIs in immune-desert tumours https://t
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…